Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experience.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2012
Same author

Guidelines for the welfare and use of animals in cancer research.

British journal of cancer·2010
Same author

Randomized cross-over trial comparing inpatient and outpatient administration of high-dose cisplatin.

Internal medicine journal·2010
Same author

Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer.

British journal of cancer·2006
Same author

Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026.

British journal of cancer·2005
Same author

Small molecule anticancer drugs.

IDrugs : the investigational drugs journal·2005

Related Experiment Video

Updated: Jun 3, 2026

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

Bcl-2 family immunohistochemistry.

L R Kelland1, P J Beale

  • 1CRC Centre for Cancer Therapeutics, The Institute of Cancer Research, Sutton, Surrey, UK.

Methods in Molecular Medicine
|March 5, 2011
PubMed
Summary

Immunohistochemistry of Bcl-2 family proteins is crucial for cancer research. These proteins regulate programmed cell death (apoptosis), with some inhibiting it and others promoting it, impacting cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The Bcl-2 family of proteins plays a critical role in regulating apoptosis.
  • Bcl-2, the first identified member, is implicated in B-cell lymphomas.
  • Dysregulation of apoptosis is a hallmark of cancer.

Purpose of the Study:

  • To review the growing interest in immunohistochemistry of Bcl-2 family proteins in cancer research.
  • To highlight the dual role of Bcl-2 family proteins in promoting or inhibiting apoptosis.
  • To underscore the clinical and preclinical significance of these proteins in cancer.

Main Methods:

  • Review of existing literature on Bcl-2 family proteins and immunohistochemistry.
  • Analysis of the roles of various Bcl-2 family members (e.g., Bcl-2, Bax) in apoptosis.

More Related Videos

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

Multiplex Cyclic Fluorescent Immunohistochemistry
04:21

Multiplex Cyclic Fluorescent Immunohistochemistry

Published on: January 26, 2024

Related Experiment Videos

Last Updated: Jun 3, 2026

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma
07:52

Multiplexed Fluorescent Immunohistochemical Staining, Imaging, and Analysis in Histological Samples of Lymphoma

Published on: January 9, 2019

Multiplex Cyclic Fluorescent Immunohistochemistry
04:21

Multiplex Cyclic Fluorescent Immunohistochemistry

Published on: January 26, 2024

  • Discussion of the clinical relevance of Bcl-2 family protein expression in cancer.
  • Main Results:

    • Bcl-2 family proteins are broadly classified into pro-apoptotic and anti-apoptotic members.
    • Bcl-2 acts as an anti-apoptotic protein, prolonging cell survival.
    • Other members, like Bax, are pro-apoptotic, promoting cell death.

    Conclusions:

    • Immunohistochemistry of Bcl-2 family proteins is a valuable tool for cancer research.
    • Understanding the balance of pro- and anti-apoptotic proteins is key to cancer therapy.
    • Targeting apoptosis pathways holds therapeutic potential for various cancers.